B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
JHEP Rep
; 4(5): 100460, 2022 May.
Article
em En
| MEDLINE
| ID: mdl-35368991
AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AP, alkaline phosphatase; AST, aspartate aminotransferase; Autoimmune hepatitis; B-cell immunity; BAFF; BAFF, B-cell activating factor of the tumour necrosis family; Biochemical remission; GGT, gamma-glutamyltransferase; IL-21; LKM-1, liverkidneymicrosomal type 1; MRCP, magnetic resonance cholangiopancreaticography; PBC, primary biliary cholangitis; PBMC, peripheral blood mononuclear cell; PSC, primary sclerosing cholangitis; UDCA, ursodeoxycholic acid; ULN, upper limit of normal
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article